The salivary gland epithelial cells of patients with primary Sjögren's syndrome manifest significantly reduced responsiveness to 17β-estradiol

Journal of Autoimmunity

Volumn 39, Issue 1-2, 2012, Pages 64-68

  Manoussakis, M N ^a   Tsinti, M ^a   Kapsogeorgou, E K ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

E2; Estrogen receptors; Estrogens; IFN ; MSG; Salivary gland epithelial cells; SGEC; Sj gren's syndrome; SS

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 1; ESTROGEN RECEPTOR BETA 2; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSAY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SALIVARY GLAND EPITHELIUM CELL; SJOEGREN SYNDROME; UPREGULATION;

CELL ADHESION MOLECULES; CELL LINE; EPITHELIAL CELLS; ESTRADIOL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; RECEPTORS, ESTROGEN; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 84862503858     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.01.005     Document Type: Article

References (38)

1. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2010, 35:219-224.
2. Moutsopoulos H.M. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
3. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.
4. Mariette X., Gottenberg J.E. Pathogenesis of Sjogren's syndrome and therapeutic consequences. Curr Opin Rheumatol 2010, 22:471-477.
5. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
6. Ishimaru N., Arakaki R., Watanabe M., Kobayashi M., Miyazaki K., Hayashi Y. Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen-deficient mice of healthy background. Am J Pathol 2003, 163:1481-1490.
7. Ishimaru N., Arakaki R., Omotehara F., Yamada K., Mishima K., Saito I., et al. Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands. Mol Cell Biol 2006, 26:2924-2935.
8. Ishimaru N., Saegusa K., Yanagi K., Haneji N., Saito I., Hayashi Y. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through fas-mediated apoptosis. Am J Pathol 1999, 155:173-181.
9. Arakaki R., Nagaoka A., Ishimaru N., Yamada A., Yoshida S., Hayashi Y. Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background. Am J Pathol 2009, 174:1715-1724.
10. Shim G.J., Warner M., Kim H.J., Andersson S., Liu L., Ekman J., et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci U S A 2004, 101:12628-12633.
11. Tsinti M., Kassi E., Korkolopoulou P., Kapsogeorgou E., Moutsatsou P., Patsouris E., et al. Functional estrogen receptors alpha and beta are expressed in normal human salivary gland epithelium and apparently mediate immunomodulatory effects. Eur J Oral Sci 2009, 117:498-505.
12. Manoussakis M.N., Kapsogeorgou E.K. The role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 2007, 32:225-230.
13. Manoussakis M.N., Moutsopoulos H.M. Sjogren's syndrome: current concepts. Adv Intern Med 2001, 47:191-217.
14. Kapsogeorgou E.K., Dimitriou I.D., Abu-Helu R.F., Moutsopoulos H.M., Manoussakis M.N. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjogren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 2001, 124:126-133.
15. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
16. Herynk M.H., Fuqua S.A. Estrogen receptor mutations in human disease. Endocr Rev 2004, 25:869-898.
17. Forsblad-d'Elia H., Carlsten H., Labrie F., Konttinen Y.T., Ohlsson C. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab 2009, 94:2044-2051.
18. Spaan M., Porola P., Laine M., Rozman B., Azuma M., Konttinen Y.T. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjogren's syndrome. J Cell Mol Med 2009, 13:1261-1270.
19. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008, 70:165-190.
20. Komagata S., Nakajima M., Tsuchiya Y., Katoh M., Kizu R., Kyo S., et al. Decreased responsiveness of naturally occurring mutants of human estrogen receptor alpha to estrogens and antiestrogens. J Steroid Biochem Mol Biol 2006, 100:79-86.
21. Kassi E., Moutsatsou P. Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus. J Biomed Biotechnol 2010, 2010:317452.
22. Walker S.E. Estrogen and autoimmune disease. Clin Rev Allergy Immunol 2011, 40:60-65.
23. Kisiel B.M., Kosinska J., Wierzbowska M., Rutkowska-Sak L., Musiej-Nowakowska E., Wudarski M., et al. Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta. Lupus 2011, 20:85-89.
24. Imbert Y., Foulks G.N., Brennan M.D., Jumblatt M.M., John G., Shah H.A., et al. MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients. Exp Eye Res 2009, 88:334-338.
25. Richards S.M., Sullivan D.A. Do genetic alterations in sex steroid receptors contribute to lacrimal gland disease in Sjogren's syndrome?. Open Endocrinol J 2009, 3:5-11.
26. Karpuzoglu E., Zouali M. The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol 2011, 40:16-26.
27. Manoussakis M.N., Spachidou M.P., Maratheftis C.I. Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 2010, 35:212-218.
28. Rider V., Jones S.R., Evans M., Abdou N.I. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol 2000 May, 95:124-134.
29. Lin H.L., Yen J.H., Chiou S.S., Tsai W.C., Ou T.T., Wu C.C., et al. Estradiol upregulates calcineurin expression via overexpression of estrogen receptor alpha gene in systemic lupus erythematosus. Kaohsiung J Med Sci 2011, 27:125-131.
30. Rider V., Jones S., Evans M., Bassiri H., Afsar Z., Abdou N.I. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 2001, 28:2644-2649.
31. Gorjestani S., Rider V., Kimler B.F., Greenwell C., Abdou N.I. Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity. Lupus 2008, 17:548-554.
32. Walters E., Rider V., Abdou N.I., Greenwell C., Svojanovsky S., Smith P., et al. Estradiol targets T cell signaling pathways in human systemic lupus. Clin Immunol 2009, 133:428-436.
33. Jiang B., Sun L., Hao S., Li X., Hou Y. Estrogen distinctively modulates spleen DC from (NZB x NZW) F1 female mice in various disease development stages. Cell Immunol 2007, 248:95-102.
34. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 2003, 170:114-122.
35. Kouro T., Medina K.L., Oritani K., Kincade P.W. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood 2001, 97:2708-2715.
36. Stice J.P., Knowlton A.A. Estrogen, NFkappaB, and the heat shock response. Mol Med 2008, 14:517-527.
37. Geraldes P., Gagnon S., Hadjadj S., Merhi Y., Sirois M.G., Cloutier I., et al. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway. Cardiovasc Res 2006, 71:566-573.
38. Karpuzoglu E., Phillips R.A., Dai R., Graniello C., Gogal R.M., Ahmed S.A. Signal transducer and activation of transcription (STAT) 4beta, a shorter isoform of interleukin-12-induced STAT4, is preferentially activated by estrogen. Endocrinology 2009, 150:1310-1320.